Ignite Creation Date:
2025-12-24 @ 12:13 PM
Ignite Modification Date:
2026-04-13 @ 9:28 PM
Study NCT ID:
NCT00834561
Status:
COMPLETED
Last Update Posted:
2024-08-19
First Post:
2009-01-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions
Sponsor:
Teva Pharmaceuticals USA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
01305
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
Teva Pharmaceuticals USA